S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

ACRS Aclaris Therapeutics Inc

2.46

-0.14 (-5.38%)

Last Updated: 09:53:45

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Aclaris Therapeutics Charts.

Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Aclaris Therapeutics Charts.

Aclaris Therapeutics Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Friday 3 January 2025 (3 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 3 January 2025 (3 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 3 January 2025 (3 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 3 January 2025 (3 days ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Wednesday 1 January 2025 (4 days ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Tuesday 31 December 2024 (6 days ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Thursday 19 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 12 December 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 6 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 3 December 2024 (1 month ago) • Edgar (US Regulatory)

Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Tuesday 3 December 2024 (1 month ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 3 December 2024 (1 month ago) • Edgar (US Regulatory)

More Aclaris Therapeutics Inc News Articles

Lehman Brothers Financial (CE)

Northwest Biotherapeutics (QB)

Elite Pharmaceuticals (QB)

Tonix Pharmaceuticals

Rennova Health (CE)

Fannie Mae (QB)

Bioelectronics (PK)

Code Green Apparel (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions